IPHA
Innate Pharma
IPHA
IPHA
11 hedge funds and large institutions have $1.49M invested in Innate Pharma in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
$267K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$49.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
$11K |
| 4 |
Barclays
London,
United Kingdom
|
$2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $581K | -$33.5K | -8,987 | -5% |
|
2
Optiver Holding
Amsterdam,
Netherlands
| $394K | -$298K | -79,776 | -43% |
|
|
3
Millennium Management
New York
| $267K | +$212K | +57,050 | +390% |
|
4
Morgan Stanley
New York
| $184K | -$27.9K | -7,485 | -13% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $49.7K | +$49.7K | +13,315 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $11K | +$11K | +2,954 | New |
|
|
7
Barclays
London,
United Kingdom
| $2K | +$1.4K | +289 | +235% |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $1.87K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $545 | -$16.3K | -4,359 | -97% |
|
10
Citigroup
New York
| $201 | – | – | – |
|
11
BlackRock
New York
| – | -$965K | -482,645 | Closed |
|
12
Two Sigma Investments
New York
| – | -$38K | -18,789 | Closed |
|
13
Balyasny Asset Management
Chicago,
Illinois
| – | -$32K | -16,094 | Closed |
|